Article
Erythropoietin receptor is a risk factor for prognosis: a potential biomarker in lung adenocarcinoma
2022-02-24
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Lung cancer has the highest mortality rate of all cancers, and LUAD' s survival rate is particularly poor. Erythropoietin receptor (EPOR) can be detected in lung adenocarcinoma (LUAD), however, the expression levels and prognostic value of EPOR in LUAD are still unclear.<bold>Methods: </bold>Multiple bioinformatics databases, immunohistochemistry and clinicopath...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ed8cf8c7-4ef5-5bb7-9783-4e83315af1c1
- DOI
- 10.21203/rs.3.rs-1211017/v3
